Cambridge, United Kingdom
Congenica, with its slogan, "Driving Precision Medicine", is a prominent player in the digital health sector, delivering sophisticated software solutions for genomic data analysis and interpretation. Founded in 2014 in the United Kingdom, the company has built a significant reputation as an integral partner of the NHS Genomic Medicine Service, offering exclusive clinical decision support.
Initially developed from the pioneering research at the Wellcome Trust Sanger Institute and the UK NHS, Congenica optimizes healthcare operations by providing automated analysis, diagnosis, and treatment solutions globally. Its clientele spans international laboratories, academic medical centers, hospitals, and biopharmaceutical companies, indicating a robust, worldwide footprint.
The company's last funding round was a Series C investment on 04 March 2021, led by QVentures. Now part of the Seqone family, Congenica is positioned at the intersection of biotechnology, health care, and clean energy, marking it as an attractive proposition for forward-looking investors.
